Mark Boldin
Impact in
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- NF-κB Signaling Pathways
- Immunology top 0.2%
- Immune Response and Inflammation
- interferon and immune responses
Papers in
-
- MicroRNA in disease regulation 28
- Cancer-related molecular mechanisms research 12
- NF-κB Signaling Pathways 10
-
- Circular RNAs in diseases 11
- Cell death mechanisms and regulation 8
- RNA Interference and Gene Delivery 6
- Co-authors
- David Baltimore (16 shared papers)Konstantin D. Taganov (18 shared papers)David Wallach (14 shared papers)Ryan M. O’Connell (5 shared papers)Tanya Goncharov (3 shared papers)Nikolay Malinin (5 shared papers)Eugene Varfolomeev (8 shared papers)Dinesh S. Rao (7 shared papers)
- Journals
- Blood (6 papers)Proceedings of the National Academy of Sciences (6 papers)The Journal of Experimental Medicine (4 papers)The Journal of Cell Biology (3 papers)FEBS Letters (2 papers)
- Partner nations
- United StatesIsraelEstonia
In The Last Decade
Mark Boldin
53 papers receiving 16.8k citations
Mark Boldin's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 8.2k
- Immunology 6.1k
- Molecular Biology 9.9k
- Oncology 1.7k
- Neurology 342
Countries citing papers authored by Mark Boldin
This map shows the geographic impact of Mark Boldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Boldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Boldin more than expected).
Fields of papers citing papers by Mark Boldin
This network shows the impact of papers produced by Mark Boldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Boldin. The network helps show where Mark Boldin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Boldin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses Hit paper breakdown → | 2006 | 3714 |
| 2 | Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death Hit paper breakdown → | 1996 | 2062 |
| 3 | MicroRNA-155 is induced during the macrophage inflammatory response Hit paper breakdown → | 2007 | 1611 |
| 4 | MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 Hit paper breakdown → | 1997 | 1179 |
| 5 | TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS Hit paper breakdown → | 1999 | 1145 |
| 6 | MicroRNAs: new regulators of immune cell development and function Hit paper breakdown → | 2008 | 961 |
| 7 | A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain Hit paper breakdown → | 1995 | 881 |
| 8 | Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses Hit paper breakdown → | 2010 | 848 |
| 9 | miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice Hit paper breakdown → | 2011 | 727 |
| 10 | Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder Hit paper breakdown → | 2008 | 576 |
| 11 | 1995 | 338 | |
| 12 | 2011 | 316 | |
| 13 | 2007 | 299 | |
| 14 | 2012 | 242 | |
| 15 | 1997 | 204 | |
| 16 | 2012 | 196 | |
| 17 | 2008 | 174 | |
| 18 | 2015 | 167 | |
| 19 | 2014 | 165 | |
| 20 | 2016 | 151 |
About Mark Boldin
Mark Boldin is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Genetics, having authored 54 papers that have together received 17.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (28 papers), Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (11 papers), NF-κB Signaling Pathways (10 papers), Cell death mechanisms and regulation (8 papers), Immune Response and Inflammation (8 papers), interferon and immune responses (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Cancer Research (8.2k citations), Immunology (6.1k citations), Molecular Biology (9.9k citations), Oncology (1.7k citations) and Neurology (342 citations). Mark Boldin has collaborated with scholars based in United States, Israel and Estonia. Frequent co-authors include David Baltimore, Konstantin D. Taganov, David Wallach, Ryan M. O’Connell, Tanya Goncharov, Nikolay Malinin, Eugene Varfolomeev, Dinesh S. Rao, Genhong Cheng and Igor Mett. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, The Journal of Cell Biology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.